Cargando…

Access to routinely collected health data for clinical trials – review of successful data requests to UK registries

BACKGROUND: Clinical trials generally each collect their own data despite routinely collected health data (RCHD) increasing in quality and breadth. Our aim is to quantify UK-based randomised controlled trials (RCTs) accessing RCHD for participant data, characterise how these data are used and thereb...

Descripción completa

Detalles Bibliográficos
Autores principales: Lensen, Sarah, Macnair, Archie, Love, Sharon B., Yorke-Edwards, Victoria, Noor, Nurulamin M., Martyn, Meredith, Blenkinsop, Alexandra, Diaz-Montana, Carlos, Powell, Graham, Williamson, Elizabeth, Carpenter, James, Sydes, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218527/
https://www.ncbi.nlm.nih.gov/pubmed/32398093
http://dx.doi.org/10.1186/s13063-020-04329-8
_version_ 1783532816234971136
author Lensen, Sarah
Macnair, Archie
Love, Sharon B.
Yorke-Edwards, Victoria
Noor, Nurulamin M.
Martyn, Meredith
Blenkinsop, Alexandra
Diaz-Montana, Carlos
Powell, Graham
Williamson, Elizabeth
Carpenter, James
Sydes, Matthew R.
author_facet Lensen, Sarah
Macnair, Archie
Love, Sharon B.
Yorke-Edwards, Victoria
Noor, Nurulamin M.
Martyn, Meredith
Blenkinsop, Alexandra
Diaz-Montana, Carlos
Powell, Graham
Williamson, Elizabeth
Carpenter, James
Sydes, Matthew R.
author_sort Lensen, Sarah
collection PubMed
description BACKGROUND: Clinical trials generally each collect their own data despite routinely collected health data (RCHD) increasing in quality and breadth. Our aim is to quantify UK-based randomised controlled trials (RCTs) accessing RCHD for participant data, characterise how these data are used and thereby recommend how more trials could use RCHD. METHODS: We conducted a systematic review of RCTs accessing RCHD from at least one registry in the UK between 2013 and 2018 for the purposes of informing or supplementing participant data. A list of all registries holding RCHD in the UK was compiled. In cases where registries published release registers, these were searched for RCTs accessing RCHD. Where no release register was available, registries were contacted to request a list of RCTs. For each identified RCT, information was collected from all publicly available sources (release registers, websites, protocol etc.). The search and data extraction were undertaken between January and May 2019. RESULTS: We identified 160 RCTs accessing RCHD between 2013 and 2018 from a total of 22 registries; this corresponds to only a very small proportion of all UK RCTs (about 3%). RCTs accessing RCHD were generally large (median sample size 1590), commonly evaluating treatments for cancer or cardiovascular disease. Most of the included RCTs accessed RCHD from NHS Digital (68%), and the most frequently accessed datasets were mortality (76%) and hospital visits (55%). RCHD was used to inform the primary trial (82%) and long-term follow-up (57%). There was substantial variation in how RCTs used RCHD to inform participant outcome measures. A limitation was the lack of information and transparency from registries and RCTs with respect to which datasets have been accessed and for what purposes. CONCLUSIONS: In the last five years, only a small minority of UK-based RCTs have accessed RCHD to inform participant data. We ask for improved accessibility, confirmed data quality and joined-up thinking between the registries and the regulatory authorities. TRIAL REGISTRATION: PROSPERO CRD42019123088.
format Online
Article
Text
id pubmed-7218527
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72185272020-05-18 Access to routinely collected health data for clinical trials – review of successful data requests to UK registries Lensen, Sarah Macnair, Archie Love, Sharon B. Yorke-Edwards, Victoria Noor, Nurulamin M. Martyn, Meredith Blenkinsop, Alexandra Diaz-Montana, Carlos Powell, Graham Williamson, Elizabeth Carpenter, James Sydes, Matthew R. Trials Research BACKGROUND: Clinical trials generally each collect their own data despite routinely collected health data (RCHD) increasing in quality and breadth. Our aim is to quantify UK-based randomised controlled trials (RCTs) accessing RCHD for participant data, characterise how these data are used and thereby recommend how more trials could use RCHD. METHODS: We conducted a systematic review of RCTs accessing RCHD from at least one registry in the UK between 2013 and 2018 for the purposes of informing or supplementing participant data. A list of all registries holding RCHD in the UK was compiled. In cases where registries published release registers, these were searched for RCTs accessing RCHD. Where no release register was available, registries were contacted to request a list of RCTs. For each identified RCT, information was collected from all publicly available sources (release registers, websites, protocol etc.). The search and data extraction were undertaken between January and May 2019. RESULTS: We identified 160 RCTs accessing RCHD between 2013 and 2018 from a total of 22 registries; this corresponds to only a very small proportion of all UK RCTs (about 3%). RCTs accessing RCHD were generally large (median sample size 1590), commonly evaluating treatments for cancer or cardiovascular disease. Most of the included RCTs accessed RCHD from NHS Digital (68%), and the most frequently accessed datasets were mortality (76%) and hospital visits (55%). RCHD was used to inform the primary trial (82%) and long-term follow-up (57%). There was substantial variation in how RCTs used RCHD to inform participant outcome measures. A limitation was the lack of information and transparency from registries and RCTs with respect to which datasets have been accessed and for what purposes. CONCLUSIONS: In the last five years, only a small minority of UK-based RCTs have accessed RCHD to inform participant data. We ask for improved accessibility, confirmed data quality and joined-up thinking between the registries and the regulatory authorities. TRIAL REGISTRATION: PROSPERO CRD42019123088. BioMed Central 2020-05-12 /pmc/articles/PMC7218527/ /pubmed/32398093 http://dx.doi.org/10.1186/s13063-020-04329-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lensen, Sarah
Macnair, Archie
Love, Sharon B.
Yorke-Edwards, Victoria
Noor, Nurulamin M.
Martyn, Meredith
Blenkinsop, Alexandra
Diaz-Montana, Carlos
Powell, Graham
Williamson, Elizabeth
Carpenter, James
Sydes, Matthew R.
Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
title Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
title_full Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
title_fullStr Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
title_full_unstemmed Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
title_short Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
title_sort access to routinely collected health data for clinical trials – review of successful data requests to uk registries
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218527/
https://www.ncbi.nlm.nih.gov/pubmed/32398093
http://dx.doi.org/10.1186/s13063-020-04329-8
work_keys_str_mv AT lensensarah accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT macnairarchie accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT lovesharonb accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT yorkeedwardsvictoria accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT noornurulaminm accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT martynmeredith accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT blenkinsopalexandra accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT diazmontanacarlos accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT powellgraham accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT williamsonelizabeth accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT carpenterjames accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries
AT sydesmatthewr accesstoroutinelycollectedhealthdataforclinicaltrialsreviewofsuccessfuldatarequeststoukregistries